熱門資訊> 正文
Anthropic类似CRISPR的发现后，基因编辑股票下跌
2026-09-24 02:33
- Gene editing companies traded lower on Wednesday after Anthropic (ANTHRO) said that its AI model Claude has “autonomously discovered” a new enzyme system similar to the gene-editing tool CRISPR.
- Notable decliners include Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), Prime Medicine (PRME), Q32 Bio (QTTB), and LENZ Therapeutics (LENZ).
- Noting that Claude discovered the enzyme system after reviewing an expansive database of DNA sequences, Anthropic (ANTHRO) said that the involvement of its scientists in the work was limited to the initial prompt and lab work.
- The discovery marked the first for the Dario Amodei-led firm’s recently launched wet lab and signals the early evidence of Claude’s value for science ahead of the company’s highly anticipated IPO, expected as early as this year.
More on CRISPR Therapeutics, Intellia Therapeutics, etc.
- Wall Street Lunch: AI Regulation Hopes Fade After Trump Calls AI Concerns A 'Hoax'
- Anthropic And OpenAI: 'Pacing The Frontier' Or Running Out Of Steps?
- Intellia Therapeutics, Inc. (NTLA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Editas raised to Buy at Guggenheim on cholesterol therapy
- OpenAI grants Ukraine access to Daybreak to defend mounting Russian cyberattacks
推薦文章
美股前瞻 | 聯儲局再傳「鷹聲」！美債收益率應聲走高，納指期貨跌近1%；中美第八輪經貿磋商達成多項共識；Meta全面押注個人Agent
一周財經日曆 | 影響加息大事！9月大小非農數據重磅登場；美光、希音齊放榜！景旺電子、歡創科技等5只新股下周上市
Q4淨利或狂飆逾1000%！美光能否交出」炸裂「財報？三大焦點將影響股價走向
休市提醒：中秋假期來臨，港股9月25日（周五）正常開市
華盛早報 | 強勁PMI催高加息預期！納指回調1%；美財政部擬再回購60億美元長債；SpaceX總裁套現逾5200萬美元
美股前瞻 | 特朗普最新調倉曝光！拋售微軟，買入英偉達；Meta科技盛會重磅來襲；高盛、德銀齊看多：標普500將衝刺8000點
特朗普重新定義AI：美國今后將把人工智能稱為「超級智能」
特朗普將亮相聯大：聚焦伊朗 密集會見多國領導人 計劃與丹麥簽署協議
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
